ERBB2 and breast carcinoma: Substantial benefits are also seen with trastuzumab added to chemotherapy in non-metastatic breast cancer.4, 5, 6, 7, 8, 9, 10 Hence, trastuzumab combined with chemotherapy is now a standard treatment for both metastatic and early-stage, HER2-positive breast cancer.